Cargando…

Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity

Antibody–drug conjugates (ADCs) constitute a rapidly expanding category of biopharmaceuticals that are reshaping the landscape of targeted chemotherapy. The meticulous process of selecting therapeutic targets, aided by specific monoclonal antibodies’ high specificity for binding to designated antige...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onyido, Emenike Kenechi, James, David, Garcia-Parra, Jezabel, Sinfield, John, Moberg, Anna, Coombes, Zoe, Worthington, Jenny, Williams, Nicole, Francis, Lewis Webb, Conlan, Robert Steven, Gonzalez, Deyarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594448/ https://www.ncbi.nlm.nih.gov/pubmed/37873862 http://dx.doi.org/10.3390/antib12040065

Ejemplares similares

A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development
por: Healey, Gareth D., et al.
Publicado: (2019)

Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer
por: Healey, Gareth D., et al.
Publicado: (2019)

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
por: Howard, David, et al.
Publicado: (2022)

Therapeutic Potential of Microalgae-Derived Bioactive Metabolites Is Influenced by Different Large-Scale Culture Strategies
por: Garcia-Parra, Jezabel, et al.
Publicado: (2022)

Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells
por: Almars, Amany, et al.
Publicado: (2019)

Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches
por: Onyido, Emenike K., et al.
Publicado: (2016)

Progesterone Metabolism by Human and Rat Hepatic and Intestinal Tissue
por: Coombes, Zoe, et al.
Publicado: (2021)

Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021)

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?
por: Nessler, Ian, et al.
Publicado: (2018)

Experimental Evaluation of Quantum Dots and Antibodies Conjugation by Surface Plasmon Resonance Spectroscopy
por: Popov, Anton, et al.
Publicado: (2022)

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
por: Coombes, Zoe, et al.
Publicado: (2020)

Computational selection of antibody-drug conjugate targets for breast cancer
por: Fauteux, François, et al.
Publicado: (2015)

Homogeneous antibody–angiopep 2 conjugates for effective brain targeting
por: Anami, Yasuaki, et al.
Publicado: (2022)

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
por: Fu, Zhiwen, et al.
Publicado: (2022)

Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
por: Aggarwal, Devesh, et al.
Publicado: (2023)

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Design of high avidity and low affinity antibodies for in situ control of antibody drug conjugate targeting
por: Evans, Reginald, et al.
Publicado: (2022)

Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?
por: Amer, Eglal I., et al.
Publicado: (2023)

Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing
por: Lakayan, Dina, et al.
Publicado: (2018)

Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization
por: Buongervino, Samantha, et al.
Publicado: (2021)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
por: Sun, Zehua, et al.
Publicado: (2023)

Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodies
por: Shirasu, Naoto, et al.
Publicado: (2019)

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
por: Kim, Eunhee G., et al.
Publicado: (2015)

Evaluation of quantum dot conjugated antibodies for immunofluorescent labelling of cellular targets
por: Francis, Jennifer E, et al.
Publicado: (2017)

Antibody–drug conjugates in solid tumors: a look into novel targets
por: Criscitiello, Carmen, et al.
Publicado: (2021)

Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
por: Suarez-Kelly, Lorena P., et al.
Publicado: (2021)

Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency
por: Van Zundert, Indra, et al.
Publicado: (2021)

Targeting CD56 with an antibody–drug conjugate in Merkel cell carcinoma
por: Leiendecker, L., et al.
Publicado: (2021)

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours
por: Yan, Hengkang, et al.
Publicado: (2022)

Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy
por: Xing, Lijie, et al.
Publicado: (2023)

Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability
por: Ascione, Liliana, et al.
Publicado: (2023)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021)

Drug Target Identification and Elucidation of Natural Inhibitors for Bordetella petrii: An In Silico Study
por: Rath, Surya Narayan, et al.
Publicado: (2016)

CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110
por: Domínguez, Juan Manuel, et al.
Publicado: (2020)

CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells
por: Liang, Shujing, et al.
Publicado: (2015)

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies
por: Kim, S Y, et al.
Publicado: (2015)

Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells
por: Otis, James B., et al.
Publicado: (2016)

Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases
por: Yap, May Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a6snhntnvcnlmjvresv42pb492